In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Nexell Therapeutics and Diaclone sign licensing agreements
Nexell Therapeutics initiates program to develop tumour cell test
Nexell receives U.S. patent for In Vitro-derived neutrophil precursor cells
Nexell licenses tumor antibody
Nexell Therapeutics signs definitive agreement with Baxter
Nexell licenses cancer epitopes from Epimmune
Nexell receives genetic modification patent
Incyte and Lilly expand protein agreement
Nexell and Takara Shuzo form strategic alliance
Tepnel signs two year global distribution agreement with Abcam
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
